World's Best Scientists 2026 revealed!
Colleen M. Niswender

Colleen M. Niswender

D-Index & Metrics

Neuroscience

D-Index
59
Citations
14575
World Ranking
3966
National Ranking
1802

Colleen M. Niswender publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Colleen M. Niswender sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 353 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Colleen M. Niswender D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Colleen M. Niswender sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 59 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Colleen M. Niswender is affiliated with Vanderbilt University in the United States. Their research spans key areas within biochemistry, genetics, molecular biology, and neuroscience, focusing particularly on cellular and molecular mechanisms related to neuropharmacology and neurodevelopmental disorders.

The main fields of study for Niswender include:

  • Biochemistry, Genetics and Molecular Biology
  • Neuroscience

Within these broader fields, their notable subfields of research address:

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Genetics
  • Cognitive Neuroscience
  • Pharmacology

The principal topics covered in their body of work are:

  • Neuroscience and Neuropharmacology Research
  • Receptor Mechanisms and Signaling
  • Genetics and Neurodevelopmental Disorders
  • Nicotinic Acetylcholine Receptors Study
  • Photoreceptor and optogenetics research
  • RNA regulation and disease
  • Pharmacological Receptor Mechanisms and Effects

Among recent publications by Niswender are:

  • Activating mGlu3 Metabotropic Glutamate Receptors Rescues Schizophrenia-like Cognitive Deficits Through Metaplastic Adaptations Within the Hippocampus (2021, Biological Psychiatry)
  • mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits (2021, Cell Reports)
  • Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders (2020, Genes Brain & Behavior)
  • A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes (2021, JCI Insight)
  • Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu 2 /mGlu 4 receptor heterodimers (2021, Science Signaling)

Frequent publication venues include:

  • Bioorganic & Medicinal Chemistry Letters
  • ACS Chemical Neuroscience
  • Journal of Pharmacology and Experimental Therapeutics
  • ACS Medicinal Chemistry Letters
  • The FASEB Journal

Collaborations appear significant in Niswender's research, with frequent co-authors being:

  • Craig W. Lindsley
  • P. Jeffrey Conn
  • Alice L. Rodriguez
  • Sichen Chang
  • Olivier Boutaud

Best Publications

  • Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

    Colleen M. Niswender;P. Jeffrey Conn

  • Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

    Huixian Wu;Chong Wang;Karen J. Gregory;Karen J. Gregory;Gye Won Han

  • RNA EDITING OF THE HUMAN SEROTONIN 5-HYDROXYTRYPTAMINE 2C RECEPTOR SILENCES CONSTITUTIVE ACTIVITY

    Colleen M. Niswender;Sara C. Copeland;Katharine Herrick-Davis;Ronald B. Emeson

  • Glutamate receptors as therapeutic targets for Parkinson's disease.

    Kari A. Johnson;P. Jeffrey Conn;Colleen M. Niswender

  • RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

    Colleen M Niswender;Colleen M Niswender;Katherine Herrick-Davis;Ginney E Dilley;Herbert Y Meltzer

  • Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

    P. Jeffrey Conn;Craig W. Lindsley;Jens Meiler;Colleen M. Niswender

  • Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

    Bruce J. Melancon;Corey R. Hopkins;Michael R. Wood;Kyle A. Emmitte

  • Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activity.

    Alice L. Rodriguez;Mark D. Grier;Carrie K. Jones;Elizabeth J. Herman

  • Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.

    Colleen M. Niswender;Kari A. Johnson;C. David Weaver;Carrie K. Jones

  • Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.

    Katharine Herrick-Davis;Ellinor Grinde;Colleen M. Niswender

  • Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

    Craig W. Lindsley;Kyle A. Emmitte;Corey R. Hopkins;Thomas M. Bridges

  • An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.

    Jana K Shirey;Zixiu Xiang;Darren Orton;Ashley E Brady

  • Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function

    Meredith J. Noetzel;Jerri M. Rook;Paige N. Vinson;Hyekyung P. Cho

  • Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.

    Joy E. Marlo;Colleen M. Niswender;Emily L. Days;Thomas M. Bridges

  • RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.

    Kelly A Berg;Jodie D Cropper;Colleen M Niswender;Elaine Sanders-Bush

  • ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.

    Kristian Kaufmann;Ian Romaine;Emily Days;Conrado Pascual

  • Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents

    Michael Bubser;Thomas M Bridges;Thomas M Bridges;Ditte Dencker;Robert W Gould

  • Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release

    Daniel J. Foster;Jermaine M. Wilson;Daniel H. Remke;M. Suhaib Mahmood

  • A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.

    Douglas J. Sheffler;Richard Williams;Thomas M. Bridges;Zixiu Xiang

  • Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS

    Shen Yin;Meredith J Noetzel;Kari A Johnson;Rocio Zamorano

  • The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

    Carrie K. Jones;Michael Bubser;Analisa D. Thompson;Jonathan W. Dickerson

  • A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors

    Colleen M. Niswender;Kari A. Johnson;Qingwei Luo;Jennifer E. Ayala

Frequent Co-Authors

P. Jeffrey Conn
P. Jeffrey Conn Vanderbilt University
Craig W. Lindsley
Craig W. Lindsley Vanderbilt University
Carrie K. Jones
Carrie K. Jones Vanderbilt University
C. David Weaver
C. David Weaver Vanderbilt University
Shaun R. Stauffer
Shaun R. Stauffer Cleveland Clinic
Michael Bubser
Michael Bubser Vanderbilt University
Nicholas J. Brandon
Nicholas J. Brandon Neumora Therapeutics Inc
Richard A Williams
Richard A Williams Heriot-Watt University
Jürgen Wess
Jürgen Wess National Institutes of Health
Jens Meiler
Jens Meiler Vanderbilt University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens the door to a wide range of rewarding careers. Many students choose to enhance their prospects by pursuing psyd programs online. These programs are ideal for those interested in advanced roles such as clinical psychology or therapeutic practice, offering the flexibility needed for working professionals.

Another popular pathway is the online masters mft degree, which prepares graduates for careers as marriage and family therapists. This specialized role is closely related to neuroscience, given the focus on human behavior, relationships, and mental well-being.

For those aiming to fast-track their studies, accelerated degree programs online offer a quicker route to graduation. These programs allow motivated students to complete their degrees in less time and start their science or healthcare careers sooner.

When considering career options, it’s worth researching the highest paying bachelor degrees entry-level. Many neuroscience graduates find lucrative and fulfilling positions in fields like healthcare, biotech, and research, where the demand for skilled professionals continues to grow.

Best Scientists Citing Colleen M. Niswender

Trending Scientists

Recently Published Articles